SWEEPING: " Sweeper " and Epiretinal Membrane Surgery

Sponsor
Nantes University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03350607
Collaborator
(none)
20
1
72
0.3

Study Details

Study Description

Brief Summary

Epiretinal membrane (ERM) is a pathological phenomenon requiring surgery when vision is altered.

ERM surgery requires ERM peeling, then active internal limiting membrane (ILM) peeling if it is not spontaneously peeled with ERM. Initiation of peeling is very delicate and can lead to micro scotoma when realized with microscopic forceps. The Sweeper is a microscopic tool with a soft silicon tip covered with diamond dust which allows peeling initiation without retina prehension. It may reduce retinal trauma and visual sequelae.

Purpose of our study is to evaluate use of sweeper during 20 ERM surgeries. The investigator will compare microperimetry before surgery versus those after 1 month (M1) and 3 months (M3), and measure difference of number and depths of micro scotoma.

The investigator will note: number of forceps uses if sweeper is inefficient and all areas of sweeper use to correlate them with micro scotoma.

The investigator will evaluate visual and optical coherence tomography improvement after surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Non interventional study

Detailed Description

Epiretinal membrane (ERM) is a pathological phenomenon that leads to visual loss, visual distortions, central scotoma, and diplopia. No medical treatment is yet available.

ERM surgery requires separation of normal retina and epiretinal membrane. After epiretinal peeling, if internal limiting membrane (ILM) is not spontaneously peeled with ERM, surgeon peels ILM from retina (also named active peeling). Initiation of peeling is very accurate and delicate. Either microscopic forceps or sweeper are used to initiate peeling. Sweeper is a microscopic tool with a soft silicon tip covered with diamond dust which allows peeling initiation without retina prehension. It may reduce retinal trauma and visual sequelae.

ILM active peeling reduces recurrence of ERM and rate of repeat surgery. No visual acuity loss has been found. But 2 studies show increase of micro scotoma at micro-perimetry after active ILM peeling with forceps.

Purpose of our study is to evaluate use of sweeper during 20 ERM surgeries. The investigator will compare microperimetry before surgery versus those after 1 month (M1) and 3 months (M3), and measure difference of number and depths of micro scotoma.

The investigator will note: number of forceps uses if sweeper is inefficient, all areas of sweeper use to correlate them with micro scotoma.

The investigator will evaluate visual and optical coherence tomography improvement after surgery.

Our study doesn't include any intervention while surgeries would be realized with or without study participation. Examinations are non-invasive, usual, and done during usual medical visit without additional visit.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observational Prospective Monocentric Study Evaluating "Sweeper" Use During Epiretinal Membrane Surgery
Actual Study Start Date :
Jan 24, 2018
Anticipated Primary Completion Date :
Jan 24, 2024
Anticipated Study Completion Date :
Jan 24, 2024

Outcome Measures

Primary Outcome Measures

  1. Difference of number and depth of micro scotoma before and after epiretinal membrane (ERM) surgery with sweeper [microperimetry at baseline, then 1 month after surgery (M1), then 3 months after (M3)]

Secondary Outcome Measures

  1. Efficacy of sweeper mesured by number of forceps uses if sweeper is inefficient [Day of surgery]

  2. Visual improvement measured by visual acuity and optical coherence tomography improvement after surgery , visual acuity and OCT morphometry before surgery, M1 and M3 [at baseline, then 1 month after surgery (M1), then 3 months after (M3)]

  3. Optical coherence tomography (OCT) improvement after surgery measured by OCT morphometry [at baseline, then 1 month after surgery (M1), then 3 months after (M3)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • consent,

  • adult patient,

  • Epiretinal membrane

Exclusion Criteria:
  • perimetry impossible

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nantes University Hospital Nantes France 44000

Sponsors and Collaborators

  • Nantes University Hospital

Investigators

  • Principal Investigator: Jean-Baptiste Ducloyer, Dr, Nantes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT03350607
Other Study ID Numbers:
  • RC17_0295
First Posted:
Nov 22, 2017
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nantes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2022